Arytha Biosciences (United States)

Recent papers from Arytha Biosciences (United States)

1. Predictors of Patient and Physician Assessments of Gout ControlArthritis Care & Research · 2022
2. Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy VolunteersClinical Pharmacology in Drug Development · 2019
3. The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With GoutThe Journal of Clinical Pharmacology · 2018
4. Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical TrialArthritis & Rheumatology · 2017
5. Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work ProductivityThe Journal of Rheumatology · 2016
6. Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activationNature Communications · 2015
7. Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced CancerClinical Cancer Research · 2013
8. Phase 2a Randomized Controlled Trial of Short-Term Activity, Safety, and Pharmacokinetics of a Novel Nonnucleoside Reverse Transcriptase Inhibitor, RDEA806, in HIV-1-Positive, Antiretroviral-Naive SubjectsAntimicrobial Agents and Chemotherapy · 2010